Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice

被引:0
|
作者
Arbeit, JM
Riley, RR
Huey, B
Porter, C
Kelloff, G
Lubet, R
Ward, JM
Pinkel, D
机构
[1] Univ Calif San Francisco, Mt Zion Med Ctr, Dept Surg, San Francisco, CA 94143 USA
[2] NCI, Div Canc Chemoprevent, Bethesda, MD 20262 USA
[3] Roswell Pk Mem Canc Ctr, Grace Canc Drug Ctr, Buffalo, NY 14263 USA
[4] NCI, Off Lab & Anim Sci, Vet & Tumor Pathol Sect, Frederick, MD 21702 USA
[5] Univ Calif San Francisco, Ctr Canc, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To be informative for chemoprevention, animal models must both closely emulate human disease and possess surrogate endpoint biomarkers that facilitate rapid drug screening. This study elucidated site-specific histopathological and biochemical surrogate endpoint biomarkers of spontaneous epidermal carcinogenesis in K14-HPV16 transgenic mice and demonstrated that the incidence and severity of these markers were decreased by the ornithine decarboxylase (ODC) inhibitor difluoromethylornithine (DFMO), The cumulative incidence of visible epidermal cancers in 127 untreated transgenic mice was 42% by 52 weeks of age, most frequently affecting the chest as flat lesions in association with chronic ulcers, or in the ear as protuberant masses. Microscopic malignancies were detected in 39% of 32-week-old transgenic mice and were found to emerge from precursor lesions that were of two distinct types: dysplastic sessile ear papillomas and hyperproliferative follicular/interfollicular chest dysplasias, ODC activity and tissue polyamine contents were differentially elevated in ear and chest skin during carcinogenesis, such that there was a marked elevation of both parameters of polyamine metabolism as early as 4 weeks of age in the ear, whereas in the chest, polyamine metabolism was increased significantly only in the late stages of neoplastic progression and in epidermal cancers. Administration of 1.0% DFMO in the drinking water from 4 to 32 weeks of age prevented both visible and microscopic malignancies and significantly decreased the incidence of chest and ear precursor lesions, ODC activity and tissue putrescine content were markedly diminished by DFMO chemoprevention in ear skin, whereas there was a more modest decline of these parameters in chest skin. DFMO treatment of transgenic mice from 28 to 32 weeks of age was associated with an absence of ear cancer and a marked regression of dysplastic papillomas, In contrast, the results in chest skin were complex in that the severity of chest precursors diminished, but their incidence was unchanged, and microscopic cancers were still detectable within these lesions. Collectively, this study highlights the utility of multistage epidermal carcinogenesis in K14-HPV16 transgenic mice both for the study of the biology of, and as a screening tool for, novel drugs and chemopreventive regimens.
引用
收藏
页码:3610 / 3620
页数:11
相关论文
共 50 条
  • [1] Cystatin C Deficiency Promotes Epidermal Dysplasia in K14-HPV16 Transgenic Mice
    Yu, Weifang
    Liu, Jian
    Shi, Michael A.
    Wang, Jianan
    Xiang, Meixiang
    Kitamoto, Shiro
    Wang, Bing
    Sukhova, Galina K.
    Murphy, George F.
    Orasanu, Gabriela
    Grubb, Anders
    Shi, Guo-Ping
    PLOS ONE, 2010, 5 (11):
  • [2] Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor
    Masset, Anne
    Maillard, Catherine
    Sounni, Nor Eddine
    Jacobs, Nathalie
    Bruyere, Francoise
    Delvenne, Philippe
    Tacke, Marlene
    Reinheckel, Thomas
    Foidart, Jean-Michel
    Coussens, Lisa M.
    Noel, Agnes
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (02) : 283 - 293
  • [3] Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice
    Arbeit, JM
    Olson, DC
    Hanahan, D
    ONCOGENE, 1996, 13 (09) : 1847 - 1857
  • [4] Oral epithelial alterations in K14-HPV16 transgenic mice.
    Murrah, VA
    Gilchrist, EP
    Arbeit, JM
    JOURNAL OF DENTAL RESEARCH, 2000, 79 : 167 - 167
  • [5] A Role for MicroRNA-155 Expression in Microenvironment Associated to HPV-Induced Carcinogenesis in K14-HPV16 Transgenic Mice
    Paiva, Isabel
    da Costa, Rui M. Gil
    Ribeiro, Joana
    Sousa, Hugo
    Bastos, Margarida
    Rocha, Ana Faustino Carlos
    Oliveira, Paula A.
    Medeiros, Rui
    PLOS ONE, 2015, 10 (01):
  • [6] Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice
    Coussens, LM
    Hanahan, D
    Arbeit, JM
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 149 (06): : 1899 - 1917
  • [7] Expression of LncRNAs in HPV-induced Carcinogenesis and Cancer Cachexia: A Study in K14-HPV16 Mice
    Dias, Tania R.
    Santos, Joana M. O.
    Estevao, Diogo
    Costa, Natalia R.
    Mestre, Veronica F.
    Medeiros-Fonseca, Beatriz
    Bastos, Margarida M. S. M.
    Oliveira, Paula A.
    Da Costa, Rui M. Gil
    Medeiros, Rui
    ANTICANCER RESEARCH, 2022, 42 (05) : 2443 - 2460
  • [8] Transcriptional profiling of dysplastic lesions in K14-HPV16 transgenic mice using laser microdissection
    Sethi, N
    Palefsky, J
    FASEB JOURNAL, 2004, 18 (09): : 1243 - +
  • [9] Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice
    SmithMcCune, K
    Zhu, YH
    Hanahan, D
    Arbeit, J
    CANCER RESEARCH, 1997, 57 (07) : 1294 - 1300
  • [10] Characterizing the Inflammatory Microenvironment in K14-HPV16 Transgenic Mice: Mast Cell Infiltration and MicroRNA Expression
    Costa, Alexandra C.
    Santos, Joana M. O.
    Medeiros-Fonseca, Beatriz
    Oliveira, Paula A.
    Bastos, Margarida M. S. M.
    Brito, Haissa O.
    da Costa, Rui M. Gil
    Medeiros, Rui
    CANCERS, 2022, 14 (09)